Seek Returns logo

BAX vs. SOLV: A Head-to-Head Stock Comparison

Updated on

Here’s a clear look at BAX and SOLV, comparing key factors like historical performance, profitability, financial strength, growth, dividend, and valuation.

Company Profile

SymbolBAXSOLV
Company NameBaxter International Inc.Solventum Corporation
CountryUnited StatesUnited States
GICS SectorHealth CareHealth Care
GICS IndustryHealth Care Equipment & SuppliesHealth Care Equipment & Supplies
Market Capitalization12.38 billion USD12.90 billion USD
ExchangeNYSENYSE
Listing DateOctober 27, 1981March 26, 2024
Security TypeCommon StockCommon Stock

Historical Performance

This chart compares the performance of BAX and SOLV by tracking the growth of an initial $10,000 investment in each. Use the tabs to select the desired time period. Data is adjusted for dividends and splits.

BAX vs. SOLV: Growth of a $10,000 investment over the past one year.

Historical Performance at a Glance

SymbolBAXSOLV
5-Day Price Return2.42%3.38%
13-Week Price Return-24.37%-0.56%
26-Week Price Return-21.75%-0.53%
52-Week Price Return-34.71%28.89%
Month-to-Date Return10.80%4.23%
Year-to-Date Return-17.32%12.59%
10-Day Avg. Volume14.95M0.95M
3-Month Avg. Volume5.66M0.96M
3-Month Volatility53.59%27.31%
Beta0.580.80

Profitability

Return on Equity (TTM)

BAX

-2.12%

Health Care Equipment & Supplies Industry

Max
34.53%
Q3
19.38%
Median
9.52%
Q1
4.86%
Min
-7.58%

BAX has a negative Return on Equity of -2.12%. This indicates the company is generating a loss for its shareholders, which can be a result of unprofitability or negative shareholder equity and is often a sign of financial distress.

SOLV

11.61%

Health Care Equipment & Supplies Industry

Max
34.53%
Q3
19.38%
Median
9.52%
Q1
4.86%
Min
-7.58%

SOLV’s Return on Equity of 11.61% is on par with the norm for the Health Care Equipment & Supplies industry, indicating its profitability relative to shareholder equity is typical for the sector.

BAX vs. SOLV: A comparison of their Return on Equity (TTM) against the Health Care Equipment & Supplies industry benchmark.

Net Profit Margin (TTM)

BAX

-1.42%

Health Care Equipment & Supplies Industry

Max
23.34%
Q3
13.06%
Median
9.53%
Q1
5.96%
Min
-3.87%

BAX has a negative Net Profit Margin of -1.42%, indicating the company is operating at a net loss as its expenses exceeded its revenues.

SOLV

4.52%

Health Care Equipment & Supplies Industry

Max
23.34%
Q3
13.06%
Median
9.53%
Q1
5.96%
Min
-3.87%

Falling into the lower quartile for the Health Care Equipment & Supplies industry, SOLV’s Net Profit Margin of 4.52% indicates weaker profitability. This means the company retains a smaller portion of each dollar in sales as profit compared to its competitors.

BAX vs. SOLV: A comparison of their Net Profit Margin (TTM) against the Health Care Equipment & Supplies industry benchmark.

Operating Profit Margin (TTM)

BAX

-0.28%

Health Care Equipment & Supplies Industry

Max
29.44%
Q3
17.80%
Median
13.95%
Q1
8.73%
Min
-3.56%

BAX has a negative Operating Profit Margin of -0.28%. This signifies the company is unprofitable at the operational level, as its core business expenses exceed its revenue.

SOLV

9.26%

Health Care Equipment & Supplies Industry

Max
29.44%
Q3
17.80%
Median
13.95%
Q1
8.73%
Min
-3.56%

SOLV’s Operating Profit Margin of 9.26% is around the midpoint for the Health Care Equipment & Supplies industry, indicating that its efficiency in managing core business operations is typical for the sector.

BAX vs. SOLV: A comparison of their Operating Profit Margin (TTM) against the Health Care Equipment & Supplies industry benchmark.

Profitability at a Glance

SymbolBAXSOLV
Return on Equity (TTM)-2.12%11.61%
Return on Assets (TTM)-0.65%2.58%
Net Profit Margin (TTM)-1.42%4.52%
Operating Profit Margin (TTM)-0.28%9.26%
Gross Profit Margin (TTM)36.01%54.64%

Financial Strength

Current Ratio (MRQ)

BAX

2.30

Health Care Equipment & Supplies Industry

Max
4.90
Q3
3.05
Median
2.14
Q1
1.49
Min
0.86

BAX’s Current Ratio of 2.30 aligns with the median group of the Health Care Equipment & Supplies industry, indicating that its short-term liquidity is in line with its sector peers.

SOLV

1.22

Health Care Equipment & Supplies Industry

Max
4.90
Q3
3.05
Median
2.14
Q1
1.49
Min
0.86

SOLV’s Current Ratio of 1.22 falls into the lower quartile for the Health Care Equipment & Supplies industry. This indicates a tighter liquidity situation and a more constrained capacity to handle short-term debt than many of its competitors.

BAX vs. SOLV: A comparison of their Current Ratio (MRQ) against the Health Care Equipment & Supplies industry benchmark.

Debt-to-Equity Ratio (MRQ)

BAX

1.30

Health Care Equipment & Supplies Industry

Max
1.49
Q3
0.71
Median
0.45
Q1
0.14
Min
0.00

BAX’s leverage is in the upper quartile of the Health Care Equipment & Supplies industry, with a Debt-to-Equity Ratio of 1.30. While this approach can boost equity growth, it also exposes the company to greater financial vulnerability.

SOLV

2.14

Health Care Equipment & Supplies Industry

Max
1.49
Q3
0.71
Median
0.45
Q1
0.14
Min
0.00

With a Debt-to-Equity Ratio of 2.14, SOLV operates with exceptionally high leverage compared to the Health Care Equipment & Supplies industry norm. This suggests an aggressive reliance on debt financing, which can magnify returns but also significantly elevates financial risk.

BAX vs. SOLV: A comparison of their Debt-to-Equity Ratio (MRQ) against the Health Care Equipment & Supplies industry benchmark.

Interest Coverage Ratio (TTM)

BAX

0.20

Health Care Equipment & Supplies Industry

Max
58.29
Q3
25.56
Median
9.06
Q1
3.60
Min
-28.92

BAX’s Interest Coverage Ratio of 0.20 is a critical concern. A value below 1.0 means operating earnings are insufficient to cover interest expenses, indicating severe financial strain and high default risk.

SOLV

2.65

Health Care Equipment & Supplies Industry

Max
58.29
Q3
25.56
Median
9.06
Q1
3.60
Min
-28.92

In the lower quartile for the Health Care Equipment & Supplies industry, SOLV’s Interest Coverage Ratio of 2.65 indicates a tighter cushion for servicing debt, suggesting less financial flexibility than many of its competitors.

BAX vs. SOLV: A comparison of their Interest Coverage Ratio (TTM) against the Health Care Equipment & Supplies industry benchmark.

Financial Strength at a Glance

SymbolBAXSOLV
Current Ratio (MRQ)2.301.22
Quick Ratio (MRQ)1.200.86
Debt-to-Equity Ratio (MRQ)1.302.14
Interest Coverage Ratio (TTM)0.202.65

Growth

Revenue Growth

BAX vs. SOLV: A side-by-side comparison of their Revenue Growth for the MRQ (YoY), TTM (YoY), 3-Year CAGR, and 5-Year CAGR periods.

EPS Growth

BAX vs. SOLV: A side-by-side comparison of their EPS Growth for the MRQ (YoY), TTM (YoY), 3-Year CAGR, and 5-Year CAGR periods.

Dividend

Dividend Yield (TTM)

BAX

3.79%

Health Care Equipment & Supplies Industry

Max
4.05%
Q3
1.76%
Median
0.71%
Q1
0.00%
Min
0.00%

With a Dividend Yield of 3.79%, BAX offers a more attractive income stream than most of its peers in the Health Care Equipment & Supplies industry, signaling a strong commitment to shareholder returns.

SOLV

0.00%

Health Care Equipment & Supplies Industry

Max
4.05%
Q3
1.76%
Median
0.71%
Q1
0.00%
Min
0.00%

SOLV currently does not pay a dividend, resulting in a yield of 0%. This is a common strategy for growth-focused companies that prioritize reinvesting earnings, though it may be less typical in mature, income-oriented sectors.

BAX vs. SOLV: A comparison of their Dividend Yield (TTM) against the Health Care Equipment & Supplies industry benchmark.

Dividend Payout Ratio (TTM)

BAX

90.20%

Health Care Equipment & Supplies Industry

Max
160.00%
Q3
72.47%
Median
27.49%
Q1
0.00%
Min
0.00%

BAX’s Dividend Payout Ratio of 90.20% is in the upper quartile for the Health Care Equipment & Supplies industry. This indicates a strong commitment to shareholder returns but also suggests that a smaller portion of earnings is retained for reinvestment compared to many peers.

SOLV

0.00%

Health Care Equipment & Supplies Industry

Max
160.00%
Q3
72.47%
Median
27.49%
Q1
0.00%
Min
0.00%

SOLV has a Dividend Payout Ratio of 0%, indicating it does not currently pay a dividend. This is a common strategy for growth-oriented companies that reinvest all profits back into the business.

BAX vs. SOLV: A comparison of their Dividend Payout Ratio (TTM) against the Health Care Equipment & Supplies industry benchmark.

Dividend at a Glance

SymbolBAXSOLV
Dividend Yield (TTM)3.79%0.00%
Dividend Payout Ratio (TTM)90.20%0.00%

Valuation

Price-to-Earnings Ratio (TTM)

BAX

--

Health Care Equipment & Supplies Industry

Max
73.48
Q3
51.69
Median
34.31
Q1
25.74
Min
11.47

P/E Ratio data for BAX is currently unavailable.

SOLV

34.03

Health Care Equipment & Supplies Industry

Max
73.48
Q3
51.69
Median
34.31
Q1
25.74
Min
11.47

SOLV’s P/E Ratio of 34.03 is within the middle range for the Health Care Equipment & Supplies industry. This suggests its valuation is in line with the sector average, representing neither a significant premium nor a discount compared to its peers.

BAX vs. SOLV: A comparison of their Price-to-Earnings Ratio (TTM) against the Health Care Equipment & Supplies industry benchmark.

Price-to-Sales Ratio (TTM)

BAX

1.14

Health Care Equipment & Supplies Industry

Max
9.53
Q3
5.26
Median
3.39
Q1
2.13
Min
0.00

In the lower quartile for the Health Care Equipment & Supplies industry, BAX’s P/S Ratio of 1.14 indicates its revenue is valued more conservatively than most of its peers. This could present a compelling opportunity if the market has overlooked its sales-generating capabilities.

SOLV

1.54

Health Care Equipment & Supplies Industry

Max
9.53
Q3
5.26
Median
3.39
Q1
2.13
Min
0.00

In the lower quartile for the Health Care Equipment & Supplies industry, SOLV’s P/S Ratio of 1.54 indicates its revenue is valued more conservatively than most of its peers. This could present a compelling opportunity if the market has overlooked its sales-generating capabilities.

BAX vs. SOLV: A comparison of their Price-to-Sales Ratio (TTM) against the Health Care Equipment & Supplies industry benchmark.

Price-to-Book Ratio (MRQ)

BAX

2.12

Health Care Equipment & Supplies Industry

Max
10.85
Q3
5.98
Median
3.48
Q1
2.43
Min
0.69

BAX’s P/B Ratio of 2.12 is in the lower quartile for the Health Care Equipment & Supplies industry. From a value investing perspective, this is favorable, as it suggests the stock is trading at a discount to its net asset value and may offer a greater margin of safety.

SOLV

3.60

Health Care Equipment & Supplies Industry

Max
10.85
Q3
5.98
Median
3.48
Q1
2.43
Min
0.69

SOLV’s P/B Ratio of 3.60 is within the conventional range for the Health Care Equipment & Supplies industry. This shows a balanced market view, where the stock’s price is neither at a significant premium nor a discount to the book value of its peers.

BAX vs. SOLV: A comparison of their Price-to-Book Ratio (MRQ) against the Health Care Equipment & Supplies industry benchmark.

Valuation at a Glance

SymbolBAXSOLV
Price-to-Earnings Ratio (TTM)--34.03
Price-to-Sales Ratio (TTM)1.141.54
Price-to-Book Ratio (MRQ)2.123.60
Price-to-Free Cash Flow Ratio (TTM)18.6555.59